Skip to main navigation Skip to search Skip to main content

Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma

  • PEACE Consortium

Research output: Contribution to journalArticlepeer-review

Abstract

Driver mutations in IDH1 and IDH2 are initiating events in the evolution of chondrosarcoma and several other cancer types. Here, we present evidence that mutant IDH1 is recurrently lost in metastatic central chondrosarcoma. This may reflect either relaxed positive selection for the mutant IDH1 locus, or negative selection for the hypermethylation phenotype later in tumor evolution. This finding highlights the challenge for therapeutic intervention by mutant IDH1 inhibitors in chondrosarcoma.

Original languageEnglish
Article number404
JournalGenome Biology
Volume26
Issue number1
DOIs
StatePublished - Dec 2025

Bibliographical note

Publisher Copyright:
© Crown 2025.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bone tumor
  • Cancer evolution
  • Chondrosarcoma
  • IDH1
  • IDH2
  • Metastasis

Fingerprint

Dive into the research topics of 'Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma'. Together they form a unique fingerprint.

Cite this